{"id":"W2121862563","doi":"10.2174/1568009615666150105115047","title":"Nano-pharmaceutical Formulations for Targeted Drug Delivery against HER2 in Breast Cancer","year":2015,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"Saskatchewan Health Authority","funders":"","keywords":"Drug delivery; Breast cancer; Monoclonal antibody; Nanotechnology; Targeted drug delivery; Nanomedicine; Drug; Cancer; Dendrimer; Liposome; Cancer therapy; Flexibility (engineering); Medicine; Pharmacology; Nanoparticle; Chemistry; Materials science; Antibody; Immunology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001330404,0.001093066,0.002376525,0.0005044882,0.000270784,0.0001768965,0.001075559,0.0002797479,0.0007459261],"category_scores_gemma":[0.00006785054,0.0009748563,0.0006854473,0.0009330399,0.0002239986,0.0006891803,0.0003645579,0.0007132959,0.0003539579],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002940776,"about_ca_system_score_gemma":0.003889095,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005274055,"about_ca_topic_score_gemma":0.000717656,"domain_scores_codex":[0.9937285,0.0004785321,0.001692826,0.001482484,0.0008798633,0.001737755],"domain_scores_gemma":[0.9966857,0.0003863502,0.0007750944,0.0007605773,0.0006704501,0.0007218718],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001378983,0.0005364884,0.0001269233,0.01283771,0.0000985078,0.00001494131,0.0003808662,0.0006218715,0.0007359186,0.0000544767,0.06726806,0.9171863],"study_design_scores_gemma":[0.00155686,0.00001017762,0.00001254677,0.009378751,0.0006800761,0.000005349785,0.0000230152,0.001073295,0.001293332,0.00008492308,0.9846745,0.00120715],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005698183,0.9729941,0.00003521103,0.0003782402,0.008001193,0.003295642,0.009329639,0.0002344856,0.00003333413],"genre_scores_gemma":[0.001553137,0.990689,0.0002604157,0.0001783969,0.001349512,0.004917108,0.0006855476,0.0002066403,0.0001602593],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9174064,"threshold_uncertainty_score":0.9992702,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06493306173260915,"score_gpt":0.3781428014225207,"score_spread":0.3132097396899116,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}